Publication:
Effect of additional inhibition of human epidermal growth factor receptor 2 with the bispecific tyrosine kinase inhibitor AEE788 on the resistance to specific EGFR inhibition in glioma cells

cris.virtual.author-orcid0000-0001-5442-9791
cris.virtualsource.author-orcidc83a9b90-5cd4-499b-90c9-b1104237fe00
datacite.rightsmetadata.only
dc.contributor.authorBerezowska, Sabina Anna
dc.date.accessioned2024-10-25T13:00:30Z
dc.date.available2024-10-25T13:00:30Z
dc.date.issued2010
dc.description.numberOfPages9
dc.description.sponsorshipInstitut für Pathologie, Klinische Pathologie
dc.identifier.publisherDOI10.3892/ijmm_00000518
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/155089
dc.language.isoen
dc.publisherSpandidos Publications
dc.relation.ispartofInternational journal of molecular medicine
dc.relation.issn1107-3756
dc.relation.organizationDCD5A442BE2AE17DE0405C82790C4DE2
dc.titleEffect of additional inhibition of human epidermal growth factor receptor 2 with the bispecific tyrosine kinase inhibitor AEE788 on the resistance to specific EGFR inhibition in glioma cells
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage721
oaire.citation.issue5
oaire.citation.startPage713
oaire.citation.volume26
oairecerif.author.affiliationInstitut für Pathologie, Klinische Pathologie
unibe.contributor.rolecreator
unibe.description.ispublishedpub
unibe.eprints.legacyId106241
unibe.journal.abbrevTitleINT J MOL MED
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Collections